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  A number of neurodegenerative diseases are accompanied by the formation of cofilin-
actin rods in neural cells. These rods can cause synaptic dysfunction and block transport within 
neurites. The overall goal of this project is to create an optogenetic switch that incorporates both 
cofilin (an actin-binding protein) and actin for the study of cofilin-actin rod formation in neural 
cells undergoing oxidative stress. During the course of the work, a protocol has been created to 
express the protein β-actin. Protein overexpression and purification, circular dichroism, mass 
spectrometry, and electrophoresis have been utilized to isolate and characterize β-actin. Site-
directed mutagenesis has been conducted to create a series of mutants to explore which residues 
are key for nucleotide binding.  A number of challenges related to protein expression and stability 
of this protein precluded completion of these studies. As a result, we turned to mutants of 
optogenetic actin to study nucleotide binding in cells. The results from these studies indicate that 
point mutants in our actin construct, in conjunction with an optogenetic cofilin, can provide insight 
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CHAPTER 1: INTRODUCTION 
 
A number of neurodegenerative diseases are accompanied by the formation of cofilin-actin 
rods in neural cells. These rods can cause synaptic dysfunction and block transport within neurites 
(1). The overall goal of this project is to create an optogenetic switch that incorporates both cofilin 
(an actin-binding protein) and actin for the study of cofilin-actin rod formation in neural cells 
undergoing oxidative stress.  
To accomplish this, we first need to develop an actin mutant with altered nucleotide binding 
affinities for ATP and ADP. In order to achieve this goal, we will pursue the following aims: (i) 
Develop a robust expression and purification protocol for β-actin; (ii) Develop an assay for actin-
nucleotide binding based on literature precedent; (iii) Create actin mutants designed to have 
different affinities for ATP and ADP and study them by spectroscopic and calorimetric methods; 
(iv) incorporate the actin mutants into optogenetic constructs.  
1.1 Neurodegenerative Diseases 
 Neurodegenerative diseases are characterized by progressive neurological dysfunctions 
that are associated with neuron cell death in the nervous system (2). Efforts have been focused on 
defining the pathways, both cellular and molecular. There are numerous different forms of 
neurodegeneration, and each involves different proteins, with amyloid beta being one of the most 
highly studied. Defective cellular processes lead to amyloid beta (Aβ) forming oligomers which 
are directly connected to synaptic damage in neurons (3). Furthermore, the effects of mutations in 
proteins such as APP, tau, and presenilin-1 on protein oligomerization have been investigated (3). 
Abnormal activation of signaling pathways that contain these proteins can also lead to synaptic 
failure. Further investigation of these pathways may lead to the discovery of ways to stop or slow 
down the development of neurodegenerative diseases.  
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 The culmination of neurodegenerative disease progression is cell death. There are two 
morphological types of cell death: apoptosis and necrosis. Apoptosis is programmed cell death that 
occurs in multicellular organisms. Apoptosis regulates the cell population and is activated by 
extrinsic or intrinsic pathways (4). Both types of pathways activate protease enzymes (caspases) 
which initiate the execution pathway of cell death (Figure 1.1). During the extrinsic pathway, the 
caspase is activated by extracellular ligands via cell surface receptors. This occurs by the formation 
of a multiprotein complex, dubbed death-inducing signaling complex (DISC), that recruits and 
activates a pro-caspase (5). The intrinsic pathway does not involve external receptors but proceeds 
during times of cellular stress. During apoptosis, the mitochondrial outer membrane is 
permeablized. As a result, mitochondrial cytochrome c is released into the cytosol. This molecule 
binds an adaptor protein which recruits an initiator caspase, leading to the formation of a caspase-
activating multiprotein complex called the apoptosome. Once activated, initiator caspases will 
Figure 1.1 Apoptosis Pathway. Used by permission from “Knopman D. Clinical Aspects of Alzheimer's Disease. In: 
Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. Wiley-Blackwell; 2011. p. 37-50 “The two 
main pathways of apoptosis are extrinsic and intrinsic as well as a perforin/granzyme pathway. Each requires specific triggering 
signals to begin an energy-dependent cascade of molecular events. Each pathway activates its own initiator caspase (8, 9, 10) which 
in turn will activate the executioner caspase-3. However, granzyme A works in a caspase-independent fashion. The execution 
pathway results in characteristic cytomorphological features including cell shrinkage, chromatin condensation, formation of 
cytoplasmic blebs and apoptotic bodies and finally phagocytosis of the apoptotic bodies by adjacent parenchymal cells, neoplastic 
cells or macrophages. 
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cleave and activate other executioner caspases. The caspases lead to degradation of cellular 
components for apoptosis. In the final stages of apoptosis, the cytoskeletal proteins and DNA are 
degraded, leading to nuclear fragmentation, degradation of subcellular components, the collapse 
of the cytoskeleton, the formation of apoptotic bodies, and ultimately clearance of the cellular 
remains in vivo (6). 
Unlike apoptosis, which is a natural phenomenon that maintains the cell population, 
necrosis is not programmed and causes several side effects such as inflammation and cell damage 
(Table 1.1). Necrosis affects surrounding cells and tissue, whereas apoptosis does not (6). In 
apoptosis, there are no inflammatory reactions because apoptotic cells do not release their contents 
into the surrounding areas and their cellular constituents are quickly phagocytosed by the 
surroundings cells; in theory, this prevents secondary necrosis (Table 1.1). Also in apoptosis, the 
engulfing cells do not produce any other cytokines that result in anti-inflammatory actions, which 
prevents further surrounding cell damage (7).     
1.1.1 Oxidative Stress 
 Oxidative stress occurs when free radicals and their products are more abundant than 
antioxidant levels (8). Free radicals are atoms, molecules, or ions that have an unpaired valence 
electron and are very reactive. Antioxidants maintain the balance of free radicals, which can 
Table 1.1 Morphological features of apoptosis and necrosis Table 
Apoptosis Necrosis 
Single Cells or small clusters of cells Often contiguous cells 
Cell Shrinkage and Convolution Cell swelling 
Pyknosis and Karyorrhexis Karyolysis, pyknosis, and karyorrhexis 
Intact cell membrane Disrupted cell membrane 
Cytoplasm retained in apoptotic bodies Cytoplasm released 
No inflammation Inflammation usually present  
 
Table 1.1 Morphological features of apoptosis and necrosis Table was adapted from “Elmore S. Apoptosis: A Review of 
Programmed Cell Death. Toxicologic Pathology. 2007 Jun;35(4):495-516.” Comparison of morphological features of 




change and alter cells and cellular functions. Reactive oxygen species (ROS) are byproduct 
radicals that are produced by metabolic pathways such as glycolysis (8). 
The endogenous sources of ROS that play the most significant role in cellular stress are 
superoxide anion (O2¯), hydroxyl radical (●OH) and hydrogen peroxide (H2O2) (Table 1.2). 
Superoxide anions are formed by the addition of 1 electron to the molecular oxygen. This process 
is mediated by nicotine adenine dinucleotide phosphate (NADPH) oxidase or xanthine oxidase or 
by mitochondrial electron transport system. The primary site for producing superoxide anion is the 
mitochondria. Typically, electrons are transferred through mitochondrial electron transport chain 
for reduction of oxygen to water, but approximately 1 to 3% of all electrons leak from the system 
and produce superoxide (9). 
 Hydrogen peroxide is also produced by xanthine oxidase, amino acid oxidase, and NADPH 
oxidase and in peroxisomes by consumption of molecular oxygen in metabolic reactions. O2¯ itself 
can even react with H2O2 and generate 
●OH. Hydroxyl radical is the most reactive ROS (8). 
 Cigarette smoke contains many free radicals and is one common source of exogenous ROS. 
Furthermore, heavy ions like iron, copper, mercury, arsenic, lead, cadmium, and nickel can 
Table 1.2 Major endogenous oxidants. 
Oxidant Formula Reaction Equation 
Superoxide Anion 𝑂2
−. 𝑁𝐴𝐷𝑃𝐻 + 2𝑂2 ↔ 𝑁𝐴𝐷𝑃
− + 2𝑂2
−. + 𝐻+ 
2𝑂2
−. + 𝐻+ → 𝑂2 + 𝐻2𝑂2 
Hydrogen Peroxide 𝐻2𝑂2 𝐻𝑦𝑝𝑜𝑥𝑎𝑛𝑡ℎ𝑖𝑛𝑒 + 𝐻2𝑂 + 𝑂2 ⇌ 𝑋𝑎𝑛𝑡ℎ𝑖𝑛𝑒 + 𝐻2𝑂2 
𝑋𝑎𝑛𝑡ℎ𝑖𝑛𝑒 + 𝐻2𝑂 + 𝑂2 ⇌ 𝑈𝑟𝑖𝑐 𝐴𝑐𝑖𝑑 + 𝐻2𝑂 
Hydroxyl radical ●𝑂𝐻 𝐹𝑒2+ + 𝐻2𝑂2 → 𝐹𝑒
3+ + 𝑂𝐻− + ●𝑂𝐻 
Hypochlorous acid 𝐻𝑂𝐶𝑙 𝐻2𝑂2 + 𝐶𝑙
− → 𝐻𝑂𝐶𝑙 + 𝐻2𝑂 
Peroxyl radicals  𝑅𝑂𝑂● 𝑅● + 𝑂2 → 𝑅𝑂𝑂
● 
Hydroperoxyl radical 𝐻𝑂𝑂. 𝑂2
− + 𝐻2𝑂 ⇌ 𝐻𝑂𝑂
. + 𝑂𝐻− 
 





generate radicals which cause cellular damage via depletion of enzymatic activity (8). Humans 
have natural defenses against ROS and other radicals. For example, the enzyme superoxide 
dismutase (SOD), catalyzes the dismutation of superoxide into oxygen or hydrogen peroxides (10). 
Vitamins such as Vitamin A can be found in whole milk and vegetables, and they can neutralize 
radicals by donating an electron to reduce these radicals.  
 There have been many studies that show that oxidative stress, radicals, and ROS are part 
of the pathogenesis of neural degeneration in NDD and AD. One of the most extensive studies was 
performed at the Sander-Brown Center of Aging and Alzheimer’s at the University of Kentucky 
Medical Center. This study focused on the link between that oxidative stress and the pathogenesis 
of neuron degeneration, using oxidative-sensitives enzymes as markers for oxidative species in 
certain cells in the presence of external oxidants (11). 
1.1.2 Alzheimer’s disease 
 Alzheimer’s disease (AD) is the most common cause of dementia, which is a syndrome 
that results in cognitive decline and impairment (12). Dementia is assessed as interference with the 
ability to function in normal activities and a reduction from prior levels of functioning and 
performing (9). Another way to diagnose and detect cognitive impairment is through objective 
cognitive assessment. Cognitive impairments include impaired ability to acquire and remember 
new information, impaired reasoning and handling of a complex task, poor judgment, impaired 
visuospatial abilities, and changes in personality, behavior or comportment (2).  
 Alzheimer’s occurs in stages and progresses more rapidly during the middle to late years 
of life. A definite diagnosis of Alzheimer’s disease requires a histopathologic confirmation. 
However, studying brain tissue can only take place after a person is deceased. A clinical diagnosis 
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is never definite and could be misdiagnosis as Parkinson’s or any other NDD. There is a lengthy 
diagnosis process that includes: acquisition of medical history, neurologic examinations, 
psychiatric examinations, clinical examinations, neuropsychological test and laboratory studies 
(12).       
   The biochemistry of AD is characterized by the accumulation of Aβ peptide in the 
functioning part of the brain (Parenchyma) and also by the accumulation of the tau protein in 
neurofibrillary tangles (13). The Aβ peptide comes from the protein amyloid precursor protein 
(APP) which is responsible for signal transduction.  Cleavage of Aβ from APP forms a soluble, 
39-42 amino acid long peptide with a helical structure (13). However, misfolding of the peptide 
can occur, resulting in the formation of β-sheet structures and subsequent aggregation. The 
resulting rod-like structures, called fibrils, are highly insoluble and thermodynamically stable and 
structurally organized.  
   Amyloid plaques found in AD patients and in murine brains represent the final state of 
the aggregation process in vivo. They are large extracellular deposits composed of insoluble 
amyloid fibrils and intimately surrounded by dystrophic dendrites, axons, activated microglia, and 
reactive astrocytes. These can cause physical changes to the brain (13).          
 ROS and oxidative stress is part of the pathology of AD and other neurodegenerative 
diseases. Aβ binds to metal ions, and the formation of complexes with these metals can generate 
ROS such as H2O2 (14). Neurons displaying signs of oxidative stress are not necessarily 




 Actin is a protein often associated with muscle cell function but is also involved in 
numerous other processes. Actin is one of the abundant protein in eukaryotic cells (16). The protein 
is located throughout the cell, including the cytoplasm and nucleus while giving the cell structure. 
Actin is also highly conserved, with a highly similar amino acid sequence across species (17). 
 Actin was first isolated in 1943 in Hungary at the University of Szeged in the Laboratory 
of Albert Szent-Gyorgyi by Bruno Straub. It was not 
until after World War II that he was given credit for 
the discovery (18). Some years earlier (in 1859), 
Wilhelm Friedrich Kühne reported that he had found 
the component necessary for muscle contraction 
from a frog muscle (19). Today, we know this 
component as the actomyosin complex. 
 Actin has two forms: monomeric (G-actin) 
and filamentous (F-actin). Actin is a globular protein 
with three different isomers: α, β, and γ. α-actin is 
responsible for muscle contractions and is found in 
skeletal, smooth, and cardiac muscle cells. β- and γ-
actin is found in the cytoplasm of cells and are part of the cytoskeleton of all cells and plays roles 
in cell division, moiety, morphogenesis and organelle positions (16).  
Actin is 375 amino acids long and has a molecular weight of approximately 42 kDa.   Actin 
has a globular shape with two major domains, a larger inner domain, and a smaller outer domain. 
The two domains are further divided into subdomains SD 1-4 (20). Nucleotides are bound in a 
cleft between SD 2 and 4 (binding cleft) in phosphate binding loops (P1 and P2) amino acid 
Figure 1.2 Actin Ribbon Structure Used by permission 
from “Kudryashov DS, Reisler E. ATP and ADP actin 
states. Biopolymers. 2013 Apr;99(4):245-56” G-actin 
Structure. The flexible segments of actin are colored as 
follows: the phosphate binding loops P1 (a.a. 11–16) and 
P2 (a.a. 154–161) are in light and dark blue, respectively; 
the sensor loop (a.a. 70–78) is in green; the H-plug (a.a. 
264–271) is in olive; the D-loop (a.a. 40–51) is in orange; 
the W-loop (a.a. 165–172) is in red; the V-stretch (a.a. 
227–237) is in cyan; the N- and C-terminal regions are 




residues 11-16 and 154-
161. There is a 2nd cleft 
opposite of the 
Nucleotide cleft called 
the hydrophobic cleft 
where actin-binding 
proteins can bind (20) 
(Figure 1.2). β-actin is 
an ATPase and can bind 
to adenosine 
triphosphate (ATP) or adenosine diphosphate (ADP). Both nucleotides are key to the formation of 
filament actin (F-actin). ATP is essential for monomer stability.  
The structural differences between the ATP and ADP bound states of actin are fairly 
minimal. The primary difference occurs between the two loops at Ser14 and His73. These loops 
engulf the phosphates of the nucleotide (21). Ser 14 binds to the terminal phosphate of ATP. After 
hydrolysis and release of the terminal phosphate, Ser14 changes orientation to form a hydrogen-
bonding contact with the β-phosphate, while the His73 loop moves toward the nucleotide to take 
up the space that was occupied by the terminal phosphate (21).  
F-actin filaments are created from G-actin bound to ATP. In a process called treadmilling, 
they start to assemble into dimers and trimers and form stable oligomers before incorporating into 
filaments (Figure 1.3) (16). ATP/G-actin complexes assemble at the barbed end of the filament, 
while ADP/G-actin complexes dissociate from the pointed end.  
Figure 1.3 Actin Treadmilling Used by permission from Kudryashov DS, Reisler E. ATP and 
ADP actin states. Biopolymers. 2013 Apr;99(4):245-56” Schematic representation of actin 
treadmilling:  Under steady state conditions in the presence of ATP, actin protomers containing 
ADP dissociate predominantly from the minus end of the filament, exchange the nucleotide in 
the cleft from ADP to ATP, and then ATP-containing protomers associate predominantly at the 
plus end of the filament. The dissociation from the minus end is potentiated by cofilin; ADP to 
ATP exchange is promoted in solution by profilin. Both proteins sense nucleotide-dependent 
conformations of actin. Overall, ATP hydrolysis by filamentous actin fuels the translocation of 
protomers from one end of the filament to the other. 
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 F-actin is the most abundant form of actin. Non-muscle F-actins are organized into bundles 
that are found in the plasma membrane like microvilli or filopodia (18). F-actin fulfills cytoskeletal 
functions such as cell stabilization and the formation of membrane extensions (19). 
1.2.1 Actin-Binding Proteins 
 As previously discussed, actin remodeling is responsible for cell movement (17). Actin 
filaments are part of the cytoskeleton and can form high order structures or actin networks.  The 
actin cytoskeleton is highly regulated at different levels by several proteins called Actin-Binding 
Proteins (ABPs). There have been over 160 different actin-binding proteins (ABPs) identified 
which are involved in the assembly of F-actin or the organization of F-actin filaments (18). 
 Most ABPs induce the formation of F-actin to make the formation easier or to regulate the 
polymerization of F-actin by decreasing the activation energy of treadmilling either by severing or 
depolymerizing. F-actin can be manipulated in many ways, such as increasing the barbed end 
elongation rate, preventing the assembly of additional G-actin promoters, and by disassembling F-
Figure 1.4 Types of Actin Binding and functions Used by permission from “Mannherz HG. The actin cytoskeleton 
and bacterial infection. Cham, Switzerland: Springer; 2017” The effects of the diverse classes of actin-binding proteins 
(ABPs) on actin dynamics a) F-actin in equilibrium with G-actin that can be sequestered by binding to profilin. B-J) is 




actin by binding and severing. There are 
many diverse classes of ABPs with actin 
dynamics ranging from the capping to the 
severing of F-actin (Figure 1.4).  
  Treadmilling is powered by 
the ABP Profilin. Profilin enhances the ADP 
exchange of G-actin that makes ATP-G-actin 
(Figure 1.5). Profilin interacts with actin by 
binding to the binding site of actin found in 
between subdomain I and III (Figure 1.2). Profilin enhances the process of treadmilling by 
speeding up the barbed end process of polymerization and elongation. While there are other ABPs 
that assist in the same process, such as β-thymosin, profilin has a greater binding affinity for G-
actin and may be the primary facilitator of G-actin nucleotide exchange.  
 The Arp2/3 complex plays a role in the regulation of actin filaments and the actin 
cytoskeleton. It starts a side branch filament onto a “mother” filament which initiates a branched 
actin network. The complex acts as a capping protein at the pointed end that encourages rapid 
growth from the barbed end (22).  
Severing ABPs are the most important of actin-binding proteins because they maintain the 
length of F-actin and the polymerization rate. Two well-characterized severing proteins are 
Gelsolin and ADF/Cofilin. They are responsible for the breakdown of straight or branched actin 
filaments. 
Figure 1.5 Nucleation and polymerization process of F-actin. 
Used by permission from “Mannherz HG. The actin cytoskeleton 
and bacterial infection. Cham, Switzerland: Springer; 2017” The 
formation of nuclei from ATP-actin molecules and the cyclic 




Cofilin represents a family of 
proteins, including Cofilin 1 (non-
muscle), Cofilin 2 (muscle), and 
Destrin or actin depolymerizing factor 
(ADF).  Whether cofilin promotes actin 
assembly/disassembly depends upon 
the relative concentration of actin and 
other actin-binding proteins present in 
the cell (16). When the concentration of 
actin and cofilin are high enough actin 
bundles (rods), start to form. 
 Cofilin is regulated through very 
complex dynamics and extracellular 
signaling. Cofilin is deactivated by 
phosphorylation on Ser3 which inhibits 
actin binding. This is done by several 
kinases, such as LIM kinase, which 
have several downstream activations 
(23).  The dephosphorization of cofilin can be regulated by the availability of the Ser3 phosphate 
to phosphatase activity by a specific phosphatase called Slingshot. This recently identified protein 
functions both in vivo and in vitro to dephosphorylate ADF/cofilin (23). However, upstream 
regulators of slingshot have not yet been reported (24).   
1.2.2 ADF/cofilin Actin Rods  
Figure 1.6 Concentration effects of cofilin on actin dynamics Used by 
permission from Bamburg JR, Bernstein BW. Roles of ADF/cofilin in actin 
polymerization and beyond (a)  Cofilin (purple) binds preferentially to 
ADP-actin (orange) and, at low stoichiometry with respect to actin 
subunits, severs filaments, creating new barbed and pointed ends. The 
cofilin dissociates with an actin subunit in the ADP form, and nucleotide 
exchange (b) At higher stoichiometry, cofilin binds to ADP-actin, but since 
binding is cooperative, regions of the F-actin become saturated and 
stabilized in the ‘twisted form’. Severing occurs rapidly, but as the cofilin 
is sequestered on the pieces of actin, severing is not persistent. Fragments 
are further depolymerized in the presence of actin-interacting protein 1 
(Aip1) (blue) to generate monomer or can be used to nucleate growth. In 
cells under stress where ADP-actin levels are elevated, the cofilin-




 Activated cofilin (dephosphorylated at Ser3) saturates actin filaments causing them to 
bundle into rod structures (Figure 1.6). These rods can cause synaptic dysfunction and blocks 
transport within neurites. This occurs in either the nucleus or cytoplasm which halts actin 
polymerization and thus freeing ATP (16). In stressed cells, the level of ATP decreases and 
oxidation potential increases which effects cofilin activity, increasing the likelihood of cofilin-
actin rod formation. Also, during cellular stress, glycolysis is inhibited which increases ADP 
concentration. Importantly, these rods dissociate quickly following relief of the transient stress 
(Figure 1.7) (16).   
 
1.3 Previous Studies 
 Previous studies have been performed to investigate the dynamics of actin structure and 
binding. Differential scanning calorimetry (DSC) was used to monitor the thermal stability of 
actin-binding proteins to actin. This study characterizes and compares the effects of cofilin, 
twinfilin, and profilin on the unfolding of monomer actin when binding to ATP or ADP. The results 
Figure 1.7 Cofilin-actin rod formation. Used by permission from Bamburg JR, Bernstein BW. Actin dynamics and cofilin-actin rods 
in Alzheimer disease. Cytoskeleton. 2016;73(9):477-97.Pathways to Rod formation. Oxidative cross-linking of cofilin before and 
after binding to F-actin to actin monomers to induce rod assembly. Profilin Binding to actin monomers opens the nucleotide pocket 




showed that actin thermal stability depends on the identity of the bound nucleotide (25). Cofilin 
binding stabilizes both ATP-actin and ADP actin while another ABPs stabilizes either ATP or 
ADP-Actin. This DSC study, done by Pivovarova and her group at the Russian Academy of 
Sciences, provides valuable info about conformation 
changes of nucleotide binding (Figure 1.8) (25).  
Another study has used TNP-ATP (εATP). εATP 
is a fluorescent molecule that can determine whether a 
protein binds to ATP and the constants associated with 
that binding. It has a fluorescent probe which can be used 
in fluorescence spectroscopy and x-ray crystallography. 
Kinosian and his group at Albany medical college found 
the dissociation rates of ADP and ATP from actin by 
displacing bound nucleotide with large amounts of 
εATP. The time course of the fluorescent intensity 
increase upon binding to actin and a program to 
determine the dissociation rate constant (26).  
One other study shows that the loss of DNase I-
inhibition activity of actin at increased temperature was 
correlated with the thermal unfolding of actin.  The 
DNase-1 inhibition assay is a simple assay for the quantification of kinetic parameters for the 
irreversible denaturating of G-actin. The results show that actin isoforms differ in thermal stability 
and that the stability of actin depends on the nature of the bound nucleotide. In addition, a thermal 
Figure 1.8 Nucleotide Binding of Actin and Temp 
Dependence Used by permission from Pivovarova 
AV, Chebotareva NA, Kremneva EV, Lappalainen 
P, Levitsky DI. Effects of actin-binding proteins on 
the thermal stability of monomeric actin. 
Biochemistry. 2013 January;52(1):152-60 
Temperature dependencies of the excess heat 
capacity (ΔCp) of ATP−Mg−G-actin (A) and 
ADP−Mg−G-actin (B) in the absence and presence 
of cofilin-1 or twinfilin-1. The concentration of 
actin was constant (15 μM), and the molar 
concentrations of cofilin and twinfilin in the 
complexes were 15 μM. (C) DSC curves of cofilin 
(15 μM) and twinfilin (15 μM) in the absence of 




melting curve was found that showed a correlation of unfolding to the temperature (27) and the 
melting temperature (Tm) was taken of DNase-1.  
1.4 Goals/Methodology  
 The overall goal of this project is to create an optogenetic switch to control the formation 
of cofilin-actin rods. This project focuses on the nucleotide equilibrium and the nucleotide binding 
of actin. The first step in this project was the protein expression of β-actin. After establishing a 
protocol for the expression and purification of native actin, we then conducted site-directed 
mutagenesis, a technique that changes amino acid sequences by introducing mutations to the parent 
gene. Eight mutations were attempted, and residue changes were based on the 3D crystal structure 
of the nucleotide cleft of β-actin. Next, we attempted a spectroscopic assay that could test and 
analyze nucleotides binding of the expressed protein. Finally, we created an optogenetic actin 
construct, utilizing the light responsive dimerizer proteins Cryptochrome 2 and Cib. This light-
activated dimerized system is activated by blue light (488 nm) and fused, respectively, to cofilin 
and β-actin (28).  
1.4.1 SDS-PAGE 
 One of the many techniques we used to characterize our expressed protein will be an SDS-
PAGE. This technique is  used to separate biomolecules based on their molecular weight and 
electric charge. Electrophoresis has many applications. For example, it is used in DNA 
fingerprinting and detection of genetic variants. It is also used for the detection of pathogens that 
may be found in blood or other tissues (29).  
A few proteins like tubulin do not bind at this ratio, and this is one reason why some 
proteins migrate anomalously (31). Since SDS is an anionic detergent, it imparts a negative charge 
to all the proteins in the sample. More importantly, these charges swamp the inherent charge of 
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the proteins and give every protein the same charge-to-mass ratio. Because the proteins have the 
same charge-to-mass ratio, and because the gels have sieving properties, mobility becomes a 
function of molecular weight (31). 
1.4.2 Circular dichroism 
 Circular dichroism (CD) is a spectroscopic method for evaluating secondary structure, 
folding and binding properties of proteins. CD is the absorption of left and right-handed circularly 
polarized light. If the light is polarized by passing the beam through a suitable prism or filters, its 
electric field, E, will oscillate in a single plane. CD is reported in units of molar ellipticity (ΔE) 
(32). 
 Structural changes in proteins caused by the binding of ligands are an essential part of the 
mechanism of action and regulation of biological activity. CD provides an experimentally 
convenient means of detecting such changes which can be examined in different spectral regions 
In addition, CD can be used to assess the range of ligand concentrations over which structural 
changes take place, the extent of the changes in the protein of interest and (using time-resolved 
CD studies) the speed at which such changes occur. CD is especially invaluable in the study of 
peptides where X-ray crystallography is not generally practical (33).   
1.4.3 Mass Spectrometry 
 Mass Spectrometry will be used to confirm the mass of the expressed protein. Mass 
spectrometry has become a widely used tool for protein sequencing and fingerprinting (34). This 
is largely due to the introduction of soft ionization sources for analysis of biomolecules, such as 
electrospray ionization and matrix-assisted laser desorption ionization. Combined with time-of-
flight (TOF) it creates a technique that makes it easier to find the weight of expressed protein.  
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In MALDI, the sample is mixed with a matrix, and a droplet of the mixture is spotted on a 
plate and allowed to dry. The plate is hit with a very short pulse of light from a laser. Matrix 
molecules absorb energy from the incident light; this energy is used to volatilize the sample and 
transfer protons from the matrix to molecules in the sample, instantaneously forming a group of 
ions. This ionization method favors the production of ions having a single charge (35). 
The ions formed are accelerated into the source region of a TOF mass spectrometer. At 
intervals, a high voltage pulse is used to send ions into the flight tube (a field-free region), where 
they separate according to kinetic energies. The kinetic energy (KE) associated with a given ion 
can be expressed in two ways: with respect to the potential applied or with respect to the resulting 
velocity of ions (34). TOF is usually used in conjunction with MALDI because of its large mass 
range. One of the benefits of MALDI/TOF is that it tends to keep the protein intact, while other 
techniques fragment the protein, making the analysis more complicated.  
1.4.4 Protein Expression 
 Protein Expression is a technique that enables large-scale production of proteins. In 
bacterial protein overexpression, plasmid DNA is transformed into a bacterial host strain such as 
BL-21. We created recombinant protein by taking the gene of interest and cloning it in an 
expression vector, transform it into a host cell, induce and finally purification (36).  The first step 
involves the design of specific gene PCR amplification primers, followed by a screening of 
potential PCR-amplified clones for proper insert orientation. Sequence analysis of positive clones 
must be performed, to confirm that a proper reading frame has been obtained and that no PCR-
introduced errors are present (37). 
Affinity tags are commonly used in protein expression. N- and C-terminal expression tags 
are used in expression vectors to help with purification to increase protein recovery by fusing to 
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the protein of interest and used to expedite protein purification via affinity chromatography. 6X 
His repeat tags have strong interactions with transition metal ions, such as Ni2+ and Co2+ (37).  
Histidine is the amino acid that exhibits the strongest interaction with immobilized metal ion 
matrices, as electron donor groups on the histidine imidazole ring readily form coordination bonds 
with the immobilized transition metal. Peptides containing sequences of consecutive histidine 
residues are efficiently retained on IMAC column matrices. Following washing of the matrix 
material, peptides containing poly-histidine sequences can be easily eluted with imidazole thus 
increasing recovery of the target protein (38).  
 The primary goal of bacterial overexpression of actin is to isolate the required quantity of 
β-actin in its active form. Soluble proteins can be recovered with good yields (>50%), and 
insoluble proteins, which must undergo denaturation and folding cycle, can be recovered with 
more modest yields (5% to 20%). (39) Due to low quantities of soluble protein in our experimental 
trials, we decided to pursue isolation of actin from inclusion bodies. 
 Inclusion bodies are protein aggregates of a target protein that form during overexpression. 
Inclusion bodies are normally formed in the cytoplasm (Figure 1.10). If a secretion vector is used, 
they can form in the periplasmic space. Inclusion bodies are not restricted to E. coli; they can also 
form in yeast, mammalian, and insect cells. Inclusion bodies recovered from cell lysates by low-
speed centrifugation are heavily contaminated with E. coli cell wall and outer membrane 
components (40). 
Protocol: Inclusion body prep of β-actin. We started with a plasmid pNic-28 encoding a 
gene for β-actin which were later transformed into BL-21(DE3) and plated onto LB-Kan agar 
plates. We picked a single colony from the agar plate and used it to inoculate a 30 mL terrific broth 
culture which was grown overnight with shaking (200 rpm) at 30 °C. The next day we took 10 mL 
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of the culture and used that to 
inoculate 200 mL of LB-Kan 
media. The media was grown 
to mid-log phase (37 °C; 200 
rpm) than 1 mM of IPTG 
was added to the culture 
which was later incubated 
overnight at 20 °C. 
The culture was 
centrifuged at 5000 rpm, and 
4 °C and the supernatant was discarded. The pellet that left was then lysed using 10 mL B-PER/1X 
protease inhibitors. The resulting culture was centrifuged for 20 mins (14000 rpm) at 4 °C where 
the supernatant and pellet were kept in the -80 °C freezer. The supernatant was put thru a gravity 
column containing HisPur Cobalt resin. This was performed two times. The column was washed 
with wash buffer (2x 10 mL; 20 mM imidazole buffer) and then eluted with 1 M imidazole. The 
lysed (soluble) fraction was then analyzed by SDS-PAGE.  
The frozen pellet (insoluble fraction) was thawed and resuspended in 10 mL B-PER, and 
40 μL of lysozyme (200 μL of a 10 mg/mL stock; 50% glycerol solution) was added. The solution 
was then mixed well and incubated for 5 min at room temperature. Finally, 100 mL of 1:10 diluted 
B-PER reagent was added to the solution and vortexed. 
The inclusion bodies were harvested by centrifugation (15 min; 14000 rpm). The resulting 
pellets were resuspended in 100 mL 1:10 diluted B-PER reagent. Solutions were then sonicated 
on ice to reduce clumping, and this was done twice. The remaining solution which contained the 
Figure 1.9 Experimental techniques. Circular Dichroism will monitor secondary 
structure and folding of the protein. SDS-Page will be used to analyze protein 
expression and purification.. MALDI will be used to confirm molecular weight of 





in 5 mL of 50 mM 
Hepes (pH 7.5)/6 
M Guanidinium 
HCl/25 mM DTT 
and incubated at 4 
°C for 1 h, then centrifuged (14000 rpm; 10 min; 4 °C) to remove any remaining insoluble material. 
The concentration was determined by a Bradford assay. 
The protein was diluted to 1 mg/mL in HEPES solubilization buffer and then diluted once 
more into refolding buffer (5 mL sample into 45 mL refolding buffer; 50 mM glycine (pH 9)/200 
mM NaCl/5 mM EDTA/10 mM DTT/1X protease inhibitors) on ice. The resulting solution was 
mixed vigorously for 2 min. Lastly, the sample was spin concentrated, dialyzed via snake dialysis 
tubing at 4 °C overnight in 2 L of 1X Tris-buffered saline (Figure 1.11). The sample was later 
analyzed by western blot.  
Figure 1.10 Inclusion body formation Adapted from Patterson, Dustin & Lafrance, Benjamin & 
Douglas, Trevor. (2013). Rescuing Recombinant Proteins by Sequestration Into the P22 VLP. Chemical 
communications (Cambridge, England). 49. 10.1039/c3cc46517a. The probability of successfully 
expressing a soluble protein decreases considerably at molecular weights above ~60 kDa.  Proteins that 
do not express in soluble form may not be modified or folded properly, or may precipitate within E. coli 
through formation of inclusion bodies 
 
Figure 1.11 Inclusion Body preparation protocol: (1) E coli Cells are lysed, (2) the cell wall and outer membrane components 
are removed, (3) the aggregates are solubilized (or extracted) with strong protein denaturants, and (4) the solubilized, denatured 





 We want to investigate the binding site of G-actin to nucleotide(s) and how this connects 
with cofilin-actin rod formation (20). By altering the nucleotide binding site of actin to change 
nucleotide affinity, we may gain a greater understanding of cofilin-actin rod formation. To 
accomplish this goal, we used site-directed mutagenesis to introduce point mutations into the 
nucleotide binding pocket of β-actin.  
Site-directed mutagenesis is a method used to make changes to DNA sequences of a gene. 
A single amino acid change by site-directed mutagenesis can help understand the role that residue 
plays in an interaction. It requires the synthesis of a DNA primer which contains the desired 
mutation and the complementary 
DNA template around the 
mutation around the mutation site. This 
way the primer hybridizes with the DNA 
in the gene.  
The choice of mutation to make was taken into 
consideration after visual inspection of 3D crystal 
structures of β-actin. Mutations at Ser14 and Val159 were 
chosen. Ser14 has direct contact with the nucleotide as it 
hydrogen bonds with the terminal phosphate of ATP. 
Val159 was chosen because it is near the binding site so a 
bigger, “bulkier” amino may affect the binding site, and 
potentially favor ADP binding over ATP binding. Single 
 





Table 1.3 Proposed β-actin mutations. 
 
Figure 1.12 Ribbon structure of ATP binding site. 
Highlighted are the 2 amino acids of interest. 




and double mutants were made with a Quikchange II protocol.  
The QuikChange II site-directed mutagenesis kit is used to make point mutations, replace 
amino acids, and delete or insert single or multiple adjacent amino acids. The QuikChange II site-
directed mutagenesis method is performed using PfuUltra high-fidelity (HF) DNA polymerase for 
mutagenic primer-directed replication of both plasmid strands with the highest fidelity. The basic 
procedure utilizes a supercoiled double-stranded DNA vector with an insert of interest and two 
synthetic oligonucleotide primers, both containing the desired mutation. The oligonucleotide 
primers, each complementary to opposite strands of the vector, are extended during temperature 
cycling by PfuUltra HF DNA polymerase, without primer displacement. Extension of the 
oligonucleotide primers generates a mutated plasmid containing staggered nicks. Following 
temperature cycling, the product was treated with Dpn I. The Dpn I endonuclease is specific for 
methylated and hemimethylated DNA and was used to digest the parental DNA template and to 
select for mutation-containing synthesized DNA, as DNA isolated from almost all E. coli strains 
is dam methylated and therefore susceptible to Dpn I digestion. The nicked vector DNA containing 
the desired mutations is then transformed into XL1-Blue supercompetent cells, followed by 
isolation of DNA from the resulting transformants and characterization by Sanger sequencing.  
1.4.6 Optogenetics 
 Optogenetics is a field of genetic engineering that uses light to measure, manipulate, and 
control biomolecular processes (41). The tools and methods developed are used to control 
molecular signals and understand cellular functions such as protein localization and protein-protein 
interactions.  One primary advantage of optogenetics is that it can provide spatial and temporal 
control over cell signaling pathways (42).  
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 Optogenetic tools can be divided into two groups: actuators and sensors. Opsins are 
actuators that are light-gated ion channels that absorb light at a specific wavelength. When 
activated by light the channels are opened or closed. Scientists have identified a variety of naturally 
occurring microbial opsins that respond to different wavelengths of light, like blue or yellow light 
(43). These various opsins also initiate different electrochemical responses, such as nonspecific 
cation influx vs. proton efflux. Researchers have used genetic engineering to improve these natural 
opsins by inducing point mutations to alter the absorption spectrum or adding trafficking signals 
to localize opsins to the cell membrane. The most common and well-known opsin is 
Channelrhodopsin, a foundational optogenetics tool that allows the fast depolarization of neurons 
upon exposure to light through direct stimulation of ion channels. Naturally occurring 
channelrhodopsins were discovered in the green algae Chlamydomonas reinhardtii. 
Channelrhodopsin-1 (ChR1) is excited by blue light and permits nonspecific cation influx into the 
cell when stimulated. Channelrhodopsin-2 (ChR2), the first widely adopted optogenetics tool, is 
also a blue light activated cation channel. 
 In this work, photoswitchable proteins will be used to control β-actin and cofilin activity. 
Genetically encoded photo-responsive actin and cofilin will be created by mutations. A weakly 
active cofilin mutant (S3E) is attached to a protein called cryptochrome 2, which is sensitive to 
blue light, along with mCherry which is fluorophore used as a marker (28). This will be part of a 
Figure 1.13. Schematic of an Optogenetics procedure Adapted from Addgene Optogenetics. A channelrhodopsin, fused to mCherry, 
is expressed in neurons (red dots). When exposed to light of the correct wavelength, the pore opens, cations flow into the cell (yellow 




dimer system where G-actin mutants will be attached to a fluorescent construct called 
Cryptochrome Interacting β-helix-loop-helix (Cib). The Cryptochrome 2-Cib system, when 


















Figure 1.14 General strategy for the design of a genetically encoded light-activatable protein. A 
weakly active cofilin mutant (orange) is appended to the light-responsive Cry2 (navy). In the absence 
of light, the cofilin construct has no discernable effect on the cytoskeleton. Upon illumination at 488 
nm, Cry2 associates with Beta G-actin-bound Cib(green), furnishing a high, effective cofilin 
concentration, thereby promoting interaction of beta actin and cofilin.  
 
CHAPTER 2: Expression and In Vitro Studies 
2.1 Wild-Type Protein Expression 
The expression of beta-actin started with BL-21 competent cells with 1μL of the WT DNA 
being added, which had been confirmed by Sanger sequencing. The cells were incubated for 30 
minutes on ice. The cells were then "heat-shocked" at 42 °C for thirty seconds and then put back 
on the ice for 2 minutes. 600μL of Super Optimal Broth (SOC medium) which is a nutrient-rich 
bacterial growth medium used for microbiological culture, generally of Escherichia coli was added 
to the cells which are then incubated (while shaking) for about an hour at 37 °C. The cells were 
plated on a KAN plate and incubated for 24 hours at 37 °C.  
Colonies that grew were picked and inoculated overnight in 1 L of LB broth. 500 μL of 
isopropyl β-D-1-thiogalactopyranoside (IPTG) (500 mM stock solution) was added after the 
concentration of bacteria, and the optical density at 600 nm (OD600) reached 0.608. IPTG is a mock 
lactose that triggers transcription which is the beginning of gene expression. The overnight LB 
broth was then divided into 200 mL bottles and centrifuged at 5000 rpm (4 °C) for 20 minutes. A 
pellet was formed, and the supernatant was discarded. The pellet was lysed with B-PER, which is 
a cell lysis reagent that is a nonionic detergent-based solution that effectively disrupts cells and 
solubilizes native or recombinant proteins without denaturation. Protease inhibitor was added (500 
μL per 10 mL B-PER). The lysed pellet was spun down with the supernatant, and the pellet was 
separated and frozen at -80 °C for later use. 
The supernatant was put through a Coomassie SDS-PAGE gel where we tested to see if 
the supernatant contained any of the beta-actin protein. Only a trace amount was detected in the 
supernatant (Figure 2.1), so an inclusion body preparation was done on the pellet. 
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The pellet was thawed and resuspended with 10 mL of B-PER with 
added lysozyme (40 μL of a 10 mg/mL stock solution). A 1:10 dilution of 
B-PER was added to the resuspension and then sonicated. After sonication, 
it was centrifuged at 14000 rpm for 15 minutes. Sonication and 
centrifugation were repeated twice. The inclusion bodies were solubilized 
in 5 mL of 50 mM of HEPES with 
25mM of DTT and then incubated 
for an hour at 4 °C and later 
centrifuged. The protein was diluted in 1 mg/mL in HEPES 
solubilization buffer.  
The protein was diluted, dropwise, in refolding buffer 
(50 mM glycine (pH 9)/200 mM NaCl/5 mM EDTA/10 mM 
DTT/1X protease inhibitors) on ice and mixed. The refolding 
buffer was put through a spin concentrator and later dialyzed 
using snakeskin dialysis. The wild-type was put through a 
coomassie SDS-PAGE (Figure 2.2). Three very concentrated 
bands were formed which indicates an abundance of beta-
actin protein present.   
To further confirm the expression of beta-actin we 
used MALDI/TOF to establish the molecular weight of our 
protein concentrate (Figure 2.3). We detected weight of ~43 
kDa, and the molecular weight of β-actin is ~42 kDa. The 
additional mass comes from the 6X His tag and leader sequence that results from the cloning of 
Figure 2.1 SDS-PAGE Gel 
of supernatant. After the 
lysing of the pellet, the 
supernatant was analyzed 
using electrophoresis to see 
if protein had been 
expressed. Very little 
soluble protein was found 
in the supernatant. 
Figure 2.2 Coomassie Blue Gel of Pellet. A) 
After not finding abundant protein in the 
supernatant, insoluble protein was identified in 
the cell pellet. The pellet was solubilized in 
GdHCl and then refolded. The solubilized 
protein was subjected to SDS-PAGE to find 
much protein. Pictured below B) the protein 
was refolded and C) characterized by an α-




our actin gene into the pNic28 expression vector. The matrix used was 10 mg/mL sinapinnic acid 
in 70:30 acetonitrile: water with 0.3% trifluoroacetic acid. Sinapinnic acid is very a common 
matrix used for large peptides and proteins and has the ability to absorb laser radiation and donate 
protons to the analyte of interest which is the beta-actin protein.  
2.2 Circular Dichroism 
Using circular dichroism, we tried to monitor if there are any changes in the structure of 
actin when bound to different nucleotides. For these studies, we initially used purified WT actin 
from the soluble fraction of our bacterial lysate. These initial studies produce noisy CD spectra 
whose overall shapes did not match literature spectra of over-expressed β-actin (Figure 2.4).    We 
followed up these efforts by performing CD of refolded actin, prepared via the following protocol: 
500 μL of the wild-type protein (3.215 mg/mL isolated from an inclusion body prep) was added 
dropwise into 40 mL of refolding buffer with dithiothreitol (pH 9). A gravity column was made 
with Ni-NTA resin which used in expression and purification of the protein. The resin purifies 
high levels His-tagged fused proteins that are used during expression. The nickel column was first 
washed with wash buffer (20 mM PBS/imidazole). All 40 mL of the refolding buffer now 
containing the WT protein was put through the column. 10 mL of wash buffer was placed into the 
column, and then 7 mL of elution buffer was put through to elute the protein off the column. The 
imidazole is used to elute all proteins that contain the His tags. The eluted protein was then spun 
Figure 2.3 Beta-Actin MALDI/TOF. The peak labeled M+H is the analyte when a protein is absorbed and is the indicator of 
the analyte and its molecule weight. The weight is 43710 da. The literature weight of Beta-actin is about 42 kDa. The additional 
mass (1700 da) corresponds to the presence of a N-terminal 6X His affinity tag and the associated leader sequence.  
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down using a spin concentrator at 4000 rpm for 
about 40 minutes the eluted protein was spun. 
About 9 mL of protein was left, and the 
concentration was found via spectroscopic assay to 
be 0.9 mg/mL.  
The eluted protein was put through a ZEBA 
column to get rid of the imidazole. The column was 
prepared first by washing the column with G-buffer 
containing ATP to do our buffer exchange and have 
out expressed protein bind to ATP. The column 
washed and spun 3 times with G-buffer and one 
time with our eluted protein. CD was run and 
unsuccessful.  
Next, we attempted the refolding of actin in 
the presence of 2 mM Mg2+ and Ca2+ in the 
refolding buffer. Mg and Ca bind to actin and are 
important for structural integrity. The refolding 
buffer containing Mg2+/Ca2+ and our refolded WT 
actin protein was put through the nickel gravity 
column. Instead of desalting using a ZEBA 
column, snakeskin dialysis was performed in a 1:10 dilution of G-Buffer. The CD spectra indicated 
that traces of imidazole were present in the protein prep. The solution was re-dialyzed and the CD 
Figure 2.4 CD spectra of ATP-actin and ADP-actin Actin 
CD spectra were of insufficient quality. Alternate approaches 
to sample prep failed to improve the observed CD spectra. A 
CD spectrum (bottom panel, inset) of native (solid line) and 
heat denatured (dashed line) ATP-actin from Eur. J. Biochem. 




analysis repeated with no success (i.e., no spectra were observed in these studies, indicating a 
possible loss of protein during dialysis).  
2.3 Thermal Shift Assay 
These assays quantify the change in thermal denaturation temperature of protein in the 
presence of a stabilizing ligand. There are many forms of this assay, and the cellular thermal shift 
assay was performed. This method monitors the binding of protein by precipitation which is 
initiated when a protein is denatured.  
The soluble fractions of the thermally denatured proteins are analyzed by a western blot, 
which enables detection of a melting curve. First, we tested the binding affinity of our expressed 
protein to ATP. The expressed protein, along with ATP, was put through a heat gradient (55-65 
C) (Table 2.1). The sample was then centrifuged to separate soluble from insoluble protein, and 
the soluble protein was characterized by an α-actin western blot.  
 In our assay, 15 μL of dialyzed protein and G buffer (ddH2O, 2 mM Tris-Cl, 2 mM CaCl2) 
were mixed in 12 individual samples. These samples were divided in half where six samples had 
4 μL of ATP added and six without ATP. The samples were heated in a PCR thermal cycler (55 
Figure 2.5 CD Thermal Melt Curve for Actin-ATP where the Tm value is 327.3 K (.98) Actin-ADP tm value is 333.6 K (.71). 
The literature Tm value (variously reported from 58 – 61 °C) for ATP-actin did not match our results (54.15 °C). 
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°C-65 °C) and cooled for 3 min at room temperature. Protein 
was transferred to 1.5 mL tubes and centrifuged at 17000 
rpm for 20 minutes. Loading dye for a western blot was added. Transfer 
western blot was performed for 70 mins at 140 volts. The transfer 
membrane was placed in 1: 500 β-actin primary antibodies overnight in a 
rocker. The membrane was washed with TBST, and then anti-mouse 
secondary was added to 5% BSA-TBST, and then the secondary was 
added to the membrane. The membrane was put in the imager. This assay 
was unsuccessful. While we were able to observe our positive control 
band on the western blot, no bands were observed in the actin samples that were subjected to 
thermal denaturation. Once heated in the thermal cycler we did not see any bands on the western 
blot, indicating loss of all protein during the denaturation step. As a result, we then moved on to 
another method of testing the nucleotide binding of our expressed wild-type protein. 
2.4 Nucleotide Binding Assays 
We next attempted to monitor nucleotide binding of our expressed protein, both wildtype 
and mutants, after the thermal shift assay. We utilized a fluorescent analog of ATP to monitor the 
binding of ATP and ADP to our expressed protein. Numerous analogs have been synthesized and 
used to probe and study ATP. They are used in many ways including the detection of ATP binding 
sites (Figure 2.6).   
 They are many types of analogs, and they can be modified in three different ways on the 
phosphate tail, the 2, 3 ribose group, or the base of the ATP. The experiment will determine the 
type of analog that is used. For this experiment we are testing nucleotide binding to a beta-actin 
Table 2.1 Temperature Gradient 




binding site, so a phosphate tagged analog would not work. 
The 2 analogs chosen were TNP-ATP and etheno-ATP (ε-
ATP), modified at the ribose and base position respectfully 
(Figure 2.7).  
We performed an ATP exchange assay to monitor the 
exchange of regular ATP and the fluorescent ATP. An ATP-G 
buffer mixture was made which contains 1 mL of 10X G-
buffer, 9 mL of double-distilled water (ddH2O), and 3 mM of 
ATP and ADP. The expressed protein was spun with the ATP-
G buffer mix in a spin concentrator. The spun protein is 
Figure 2.6 ATP Analogues. Listed are the different types of ATP analogs. ATP analogues can be modified at the phosphate 
group, the base, and the ribose. Clive R. Bagshaw, J. Cell Science (2001), 114, 459-460. 
Figure 2.7 Analogs used in an assay. A) 




plated, and the fluorescent ATP is added and immediately put into the reader. The results were not 
conclusive and consistent results were not able to be collected. The spectra displayed a change of 
fluorescence which indicated some nucleotide binding, but concrete results were not obtained from 
this study. 
2.5 Mutagenesis 
Our site-directed mutagenesis started with a template made from the wild-type actin DNA.  
A DNA plasmid kit (EZ DNA Plasmid MIDI Kit) was used to extract DNA that would later be 
used as the template for the mutations. The method of plasmid preparation and extractions begins 
with the growth of the culture. The Actin PNIC28 was added and grown in 30 mL of kanamycin-
LB media overnight. A pellet was created by centrifugation at 4000Xg for 10 mins. The pellet was 
resuspended in RNase A then lysed using Omega's 
Lysis buffer. The pellet was then neutralized by a 
neutralization buffer and centrifugation. The 
supernatant is added to a ‘HiBand' DNA column 
where the DNA binds to a membrane on the 
column. The column is then washed 3 times with 
wash buffer, and the DNA is eluted out. The 
concentration was checked afterward, and it was 
about 200 mg/mL 
 To perform the site-directed mutagenesis, we 
added site-directed reverse and forward primers (IDT DNA, Inc.). The template and primers were 
mixed with nuclease-free water and a reaction mix from a commercial DNA polymerase kit. 
Figure 2.8 Agarose Gel for S14A/S14V primers. Lane 1: 1 
kB DNA ladder. Lanes 2-5:mutagenic PCR reactions 
generated with S14A mutagenic primers; lanes 6-9: 
mutagenic PCR reactions using the S14V primers. The PCR 
reactions from the 2nd S14A lane and the 2nd and 3rd S14V 
lanes were transformed into ultracompetent E. coli and 
transformants characterized by Sanger sequencing. 
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Thermal cycling was performed using an Eppendorf PCR thermocycler. Agarose Electrophoresis 
was performed to confirm DNA amplification.   
  The DNA that showed the greatest amplification were chosen for DPNI digest and 
transformation in ultra-competent cells (Figure 2.8). Shown in Figure 2.8 are the results of site-
directed mutagenesis PCR for the S14A and S14V primers. Transformation of the S14A primers 
did not produce any colonies. The S14V produced colonies which were picked and put into 10 mL 
of terrific broth. A plasmid preparation protocol (mid-prep) was performed, and the resulting DNA 
was sequenced. The mutants that came back that correct and ready for experimentation were the 

















CHAPTER 3: OPTOGENETICS 
3.1 Theory  
Optogenetics is a field of genetic engineering that uses light to measure, manipulate, and 
control biomolecular processes. Optogenetic tools can be used to control cell signaling.  The 
primary focus of this work is to create optogenetic constructs for the control and monitoring of 
cofilin-actin rod formation. Ultimately, we aim to study cofilin-actin rods and their role in the 
pathology of AD in neural cells.  
Cofilin-actin rod formation, which was discussed in chapter 1, is associated with AD and 
causes synaptic dysfunction of neurons. Multiple factors contribute to the formation of cofilin-
actin rods: elevated levels of active cofilin, elevated levels of ADP-actin, and a highly oxidative 
environment. The assay we perform has to simulate these conditions. We can recreate these 
conditions by inhibiting mitochondrial function by using an azide solution. Azides uncouple 
oxidative phosphorylation and inhibit ATPase activity but not the ADP-ATP exchange reaction 
(44). We can recreate high ADP concentration by putting the cell under energetic stress by 
inhibiting glycolysis. D-deoxyglucose (2-Deoxy-D-glucose) is a glucose molecule which has the 
2-hydroxyl group replaced by hydrogen so that it cannot undergo further glycolysis. As such, it 
acts as a competitive inhibitor of the production of glucose-6-phosphate from glucose. 
A flavoprotein called cryptochrome 2 (Cry2) will be used to control our optogenetic 
constructs in tandem with a beta helix loop helix (bHLH) protein called CIB. Cry2, a blue light 
photoreceptor protein from A. thaliana, and CIB comprise a light responsive protein dimerization 
module. Cry2 has a chromophore called flavin which absorbs at a wavelength of 450 nm. The 
Cry2/CIB binds together to form a dimer in blue light and dissociates in the dark. For our optical 
switch, we will utilize the proteins Cry2 infusion with mCherry (a fluorescent marker) and cofilin 
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(Cry2-mCh-Cof) and CIB infusion with actin and the fluorescent marker GFP (Actin-CIB-GFP).  
In addition to WT β-actin, we have created β-actin mutations that will also be used in our 
optogenetic construct single mutants Val159Leu, Val159Ile, Ser14Val and double mutants 
Val159Leu-Ser14Ala, and Val159Leu-Ser14Val.  
3.2 Prior Studies and Results: 
Previous Studies of cofilin-actin rods have been performed but have been hampered by 
various experimental challenges (45). For example, cofilin-actin rods have been successfully 
induced in cells in the presence of azide, but they require antibodies for detection via 
immunostaining, which prevents real-time assays of rod formation. 
In another study mutant cofilin, Cofilin R21Q was linked to a red fluorescent protein 
(mRFP) to monitor cofilin-actin rod formation. The CofR21Q-
mRFP showed oxidant-inducible rod formation, but it was 
irreversible without a change in cell media. The construct we 
plan to will be reversible, enabling greater experimental control 
(46).  
Previous studies have used the Cry2/CIB construct to 
control protein’s activities with light activation. This includes 
proteins like Cre recombinase which is an enzyme derived 
from P1 bacteriophage. It plays a role in site-specific 
recombination events and its used to manipulate DNA in both in vivo and in vitro lab work (47). 
BAX, which is part of the Bcl-2-gene family which is have been used the Cry2/CIB construct to 
Figure 3.1 Example induces rod formation 
in cultured cells. All panels are inverted 
fluorescence images. A) is GFP rods in A4.8 
cells. B), C), D) are cofilin rods in Hela cells, 
A431 cells, and rat cortical neurons 
respectively. Image reproduced from J Biol 
Chem. 2010 Feb 19;285(8):5450-60. 
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initiate cell death (48).  Our 
laboratory has created many 
cofilin mutants and fused them to 
Cry2, where Cry2 was either 
bound at the C- or N-terminus 
(Table 3.1). 
The Cry2/CIB 
interaction has also been used in 
protein translocation. Cry2/CIB 
has been used to move cytosolic 
proteins to other locations within 
a cell such as the plasma 
membrane and mitochondrial 
outer membrane in response to 
light (Figure 3.3).  
We have generated 
constructs that fuse Cry2 with 
various mutants of cofilin and 
Cib with beta-actin. In our initial 
work, we demonstrated a wild-type 
cofilin fusion fused to Cry2 (Cof. WT-Cry2-mCh) forms constitutive, light-independent 
clusters/rods under oxidative and energetic stress (Figure 3.2). This result indicates that, when 
Figure 3.2 Responses of cofilin mutants to oxidative stress. Cofilin (WT, S3A, 
and actin-binding impaired mutants) exposed to oxidative and energetic stress 
in transiently transfected HeLa cells. After 1 hour in 6mM D-deoxyglucose and 
10 mM sodium azide, significant cofilin-actin clustering is detected in the WT 
and S3A cofilins, but not in the actin binding impaired cofilins or the mCherry 
control.  Scale bar = 10 microns. 
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placed under oxidative stress, our Cry2-Cof 
fusions can interact with endogenous actins in 
a manner similar to endogenous cofilin.  
Various N- and C-terminal 
cofilin/Cry2 mutant fusions were constructed 
with beta-actin/CIB(Table 3.1). Cells were 
transfected with these various constructs and 
were put under oxidative stress and energetic 
stress.  The Cry2-Cofilin fusion Cry2-mCh-
Cof.S3E, in combination with beta-actin-CIB (Table 3.1, Row VII), demonstrated the rapid & 
reversible formation of cofilin-actin clusters in response to 488 nm light stimulation under cofilin-
actin rod forming conditions. Control experiments (conducted with optogenetic actin alone and 
optogenetic cofilin alone) demonstrated that both cofilin and actin are required for light-induced 
rod formation. Cof.S3E, which mimics the phosphorylated state of cofilin at Serine 3, does not 
Figure 3.3 Examples of light activated translocation. Blue light 
(488 nm) stimulation of transfected cells induces recruitment of 
Cry2.mCherry to F-actin (top; co-transfected with LifeAct-CIB) or 
the outer mitochondrial membrane (bottom; co-transfected with 
Tom20-CIB). 
Table 3.1 Summary of cofilin constructs. Survey of light-stimulated cofilin-actin rod formation 




bind or sever F-actin, and furthermore, cannot be dephosphorylated by SSH-1, which is the 
primary driver of cofilin activation under oxidative/energetic stress. This makes it an ideal cofilin 
mutant for inclusion in an optogenetic switch, since it is mostly bio-orthogonal, and, in contrast to 
Cof.WT will only incorporate into cofilin-actin rods in cells under oxidative/energetic stress when 
triggered with light.  
3.3 Experimental Design: 
The purpose of our experiment is to investigate whether the proposed mutations to β-actin 
favor the ATP-bound form or the ADP-bound form. We are using its interaction with cofilin under 
oxidative stress as a reporter of the nucleotide-bound state of β-actin. We monitor the nucleotide 
binding state of the β-actin under two conditions: cells with oxidant and cells without an oxidant. 
If rods and clusters form without our oxidant (10 mM Azide/6 mM D-deoxyglucose), actin is 
presumed to be primarily in the ADP-bound form of actin. If rods form with our oxidant only, then 
β-actin is presumed to be primarily in the ATP-bound form. 
To test our mutant constructs, we transfected them into a HeLa cell line, an immortal 
human cancer cell line. Cell passaging: The cells were first aspirated to remove the media present. 
The cells were washed with 5 mL of PBS. The PBS was then aspirated and discarded. About 5 mL 
of trypsin was used to wash away cells from the walls of the dish. Trypsin is a cell protease that 
breaks down all the proteins on the surface of a cell. The dishes were then put into an incubator 
for 10 mins at 37 °C. The dishes are removed from the incubator and 10 mL of cell media 
(DMEM). The media was pipetted up and down to spread the cells evenly around the dish. The 
cells were counted using a hemacytometer. After the cells are counted, they were incubated for 48 
hours and then ready for transfection.  
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3.3.1 Assembly of Optogenetic Constructs 
Cofilin and Cry2PHR were amplified separately by PCR with Phusion polymerase. After 
gel isolation of the PCR fragments, aliquots of the purified DNA fragments were combined [6 µL 
of each PCR fragment, 1.5 µL of F and R primer (20 µM stocks), 4 µL dNTPs (2.5 mM stock), 3 
µL of 10X Phusion HF buffer, 8 µL ddH2O, and 0.5 µL Phusion] and subjected to overlap 
extension PCR. The resulting appropriately sized PCR fragments were gel isolated, purified, and 
subjected to restriction digest. The resulting fragments were then ligated into mCherry-N1 with 
βsRGI and NotI sites to give Cry2-mCh-Cof.S3E. 
Our expressed WT and mutant beta-actin were 
fused with CIB to create a β-actin-CIB-GFP construct. 
CIBN and β-actin (WT and mutants) were amplified 
separately by PCR with Phusion polymerase. After gel 
isolation of the fragments, aliquots of the purified DNA 
fragments were combined (6 µL of each PCR fragment, 
1.5 µL of F and R primer (20 µM stocks), 4 µL dNTPs 
(2.5 mM stock), 3 µL of 10X Phusion HF buffer, 8 µL 
ddH2O, and 0.5 µL Phusion) and subjected to overlap 
extension PCR. The resulting construct was subjected to 
restriction digest with XhoI and HindIII enzymes and then ligated into analogously digested 
phCMV-GFP vector (Genlantis).   
Both the cofilin and β-actin were transfected into the Hela cells. A lipid-based transfection 
technique was used. We will create a 1:1 transfection solution. Solution 1 contains 1250 ng/μL of 
DNA of the protein of interest. 5 μL of P3000™ Reagent, which is an enhancer, is added along 
Figure 3.4 Western Blot of β-actin-CIB-GFP. α-
GFP western blot of transfected HeLa cell lysates 
reveals bands corresponding to: actin.S14V (lane 
1); actinV159I (lane 2); actin S14V.V159L (lane 3).  
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with 125 μL of the Opti-MEM I medium. Solution 2 contains 125 μL of the Opti-MEM medium 
and 3.73 μL of Lipofectamine which increase the transfection efficiency of RNA or plasmid DNA 
into in vitro cell cultures by lipofection. Lipofectamine reagent contains lipid subunits that can 
form liposomes in an aqueous environment, which entrap the transfection payload (49). Both are 
mixed and added to the Hela cells. The cells are then wrapped in foil to hide them from light and 
incubated for 24 hours.  
The Leica DMi8 Live Cell imaging system was used to image the cells. The infinity scanner 
allows us to manipulate the light source and record the cell activity during the experiment. Before 
imaging, we added our control PBS, which was a part of the media and to maintain normal pH. 
We took images over 10 mins with 470 nm of light and then after light exposure, capture 10 mins 
worth of images in the absence of 470 nm light. We later added the 10 mM Azide/6 mM D-
deoxyglucose oxidant to induce cell stress and rod formation.  
3.4 Results 
 Of the mutants that had been transfected, Val159Ile, Ser14Val, and double mutant 
Val159Leu-Ser14Val, the Ser14Val and Val159Leu-Ser14Val formed rods. Light-induced clusters 
of cofilin-actin were present in all three mutants (Table 3.2).  
The S14V single mutant had multiple rods form in all samples taken, with the average of 
2 rods per cell (±1) and an average length of 7.42 μm (±.68). Cofilin-actin rods had formed before 
our 10 mM Azide/6 mM D-deoxyglucose oxidant was added (Figure 3.5). Rods had already 
formed before the addition of the oxidant providing evidence that the ATP binding site has been 
changed and that ADP binding is favored (Figure 3.7). We monitored the fluorescence of the rods 
during light exposure and when the light is off. After light exposure, the fluorescence does increase 
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as the rods aggregate more of the Cry2.mCh.CofS3E but starts to plateau. When the light is not 
emitted the fluorescence decreases over time while the rods visibly shrinks in size (Figure 3.6).    
Figure 3.5 S14V mutant. Sample 1 A) The region of cells before Light exposure B) Cells after 10 mins of light exposure C) 
Cells after 10 mins of cell in the dark after initial exposure D) Graph of the amount of cluster formed and dissipated over time. 
Scale bar = 10 microns. 
Figure 3.6 Z-Plot of S14V Rods. The fluorescence of the rods are measured and when the cell is stimulated by light the rods 
overall fluorescence increases and when the cell is in darkness the fluorescence decreases. This also correlates with rod size 
and cluster count.  
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The V159L-S14V has well-defined rods and clusters (Figure 3.8 and 3.9). There is an 
Figure 3.7 S14V mutant. Sample 2 A) The region of cells before Light exposure B) Cells after 10 mins of light exposure C) 
Cells after 10 mins of cell in the dark after initial exposure D) Graph of the amount of cluster formed and dissipated over 
time. Scale bar = 10 microns. 
Figure 3.8 V159L-S14V double mutant. Sample 1 A) The region of cells before Light exposure B) Cells after 7 mins of light 
exposure C) Cells after 10 mins of cell in the dark after initial exposure D) Graph of the amount of cluster formed and 






average of 4 rods per cell (+2) with an average length of 6.22 μm (±.43). Rods were also present 
Figure 3.9 V159I-S14V double mutant. Sample 2 A) The region of cells before Light exposure B) Cells after 7 mins of light 
exposure C) Cells after 10 mins of cell in the dark after initial exposure D) Graph of the amount of cluster formed and 
dissipated over time. 
Figure 3.10 V159I Mutant. Sample 1. The cell was induced with a 10nM sodium azide solution A) The region of cells before 
Light exposure B) Cells after 10 mins of light exposure C) Cells after 10 mins of cell in the dark after initial exposure D) Graph 
of the amount of cluster formed and dissipated over time 
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before adding any oxidant meaning that ADP-actin binding is favored. As we observe the time 
lapse of the cell imaging, the number of clusters, the size or rods, and the fluorescence are all 
reversible and rapidly dissociate in the dark. 
The other successful transfection was the Val159Ile mutant. When the cells were exposed 
to just PBS, the cells did not create rods, but rapid and reversible clusters were formed. So, we 
exposed the cell with our azide solution to see if the mutation would still form rods. More clusters 
were formed but lacked rods (Figure 3.10 and 3.11) 
 
Construct PBS Only PBS With Azide 
Wild Type No Rods or Clusters Ample Amount of Clusters 
S14V Abundant Rods and Clusters Some Rods and Clusters 
V159L-S14V Abundant Rods and Clusters Abundant Rods and Clusters 
V159I No Rods or Clusters Ample Amount of Clusters 
Table 3.2 Summary of Actin 
Construct 
Survey of the 2 conditions and the 3 transfected construct in HeLa Cells. The S14V mutations created rods without the stimulated 
oxidative stress. In the presence of oxidant, the V159I mutant did have clusters displaying nuclear localization. 
Figure 3.11 V159I Mutant. Sample 2. The cell was induced with a 10nM sodium azide solution A) The region of cells before 
Light exposure B) Cells after 10 mins of light exposure C) Cells after 10 mins of cell in the dark after initial exposure D) Graph 
of the amount of cluster formed and dissipated over time 
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The V159I mutant formed 
clusters in and around the nucleus 
of the cells displaying nuclear 
localization (Figure 3.12). Recent 
research has shown that actin plays 
a role in gene transcription and 
binds to specific transcription 
factors (50). This can be used as a 
tool to study actin dependent transcription. This study showed that the single amino acid change 
for serine to valine displaced a shift in affinity to ADP-actin. The change to an amino acid that 
does not make hydrogen bonds to the terminal phosphate of ATP, likely rendering actin in its 
ADP-bound state.  Both the S14V and the V156L-S14V double mutants showed behavior 













Figure 3.12 V159I displaying nuclear localization. The cofilin-actin cluster that 
formed in the V159L exhibited light-inducible nuclear localization, which could 
be used in a separate study probing the role of actin in gene transcription. 
CHAPTER 4: CONCLUSION 
 
4.1 Summary 
The work detailed in this thesis document has shown the process of developing a protocol 
for overexpression in E. coli. Due to our low quantity yields of active β-actin protein from the 
IMAC purification method, the inclusion body prep method was used. The method produced a 
higher yield of active β-actin and then allowed us to perform several assays to assess actin.  
A variety of assays were used to test nucleotide binding of our expressed actin. Circular 
Dichroism was used to identify if there was any structural change in the expressed actin when 
bound to a nucleotide. Our experiment was based on a literature protocol, and unfortunately, 
these initial studies produced noisy CD spectra’s whose overall shape didn’t match the literature 
spectra for β-actin. We followed up by performing CD on our refolded expressed β-actin. Once 
again, no spectra were observed in these studies indicated a loss of protein during dialysis of the 
refolding process. 
The thermal shift assay was to quantify the change in thermal denaturation temperature of 
our expressed β-actin in the presence of a ligand. The method we choose as the cellular thermal 
shift which monitors the binding of protein by precipitation which is activated when a protein is 
denatured. While we were able to observe our positive control band on the western blot, no 
bands were found in the actin samples that were subjected to thermal denaturation. The next step 
is to see if the expressed protein could bind to the nucleotide. Analog ATP was used to monitor 
ATP binding and using different literature sources and protocols, etheno-ATP and TNP-ATP 
used to find binding. A spectrofluorimeter was used to detect the fluorescents of the displaced 
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ATP with the analog ATP. The results were not conclusive and consistent results were not able 
to be collected. The spectra displayed a change of fluorescence which indicated some nucleotide 
binding, but concrete results were not obtained from this study. 
Our assays with overexpressed β-actin were mostly unsuccessful, as we experienced 
problems with reproducibility. Some of these problems may be due to the challenges of 
expressing large quantities of actin in its active form. Where true success was found was our 
mutagenesis and the optogenetic constructs of cofilin and beta-actin. Hela cells were transfected 
with β-Actin – CIB- GFP (β-actin.CIB.GFP) mutants and Cry2-mCherry–CofilinS3E 
(Cry2.mCh.CofS3E), then cells were treated with different treatment solutions of Sodium Azide 
and DeoxyGlucose in PBS. Images were taken for cells before, during and post of blue light 
exposure. 
  We successfully found three mutants of beta-actin that can produce cofilin-actin rods and 
clusters when stimulated by light. The mutations S14V both single and double demonstrate a 
change in affinity to ADP while the V159I mutant shows signs of nuclear localization which can 
lead to future studies into the actin-dependent transcriptions. 
The discussion is that cofilin-actin rods only form under oxidative stress. β-actin 
nucleotide affinity is usually towards ATP where stress is needed to dephosphorylate ATP to 
ADP to form rods. The S14V and S14V-V159L double mutant both didn’t require an oxidant ( 
(PBS only) conditions to form clusters mean that we changed the affinity to an ADP affinity.  
The V159I mutant ATP-affinity didn’t change because oxidant was needed to oxidant (NaN3/D-
Deoxyglucose) to produce clusters. One of the failed essays, the analog-ATP, could be used in an 
In-vivo study to ensure our results.  
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4.2 Future work  
While the HeLa cell study was a success, we would like to introduce additional mutants 
in the nucleotide binding pocket of actin to explore if there are additional residues that introduce 
ADP-actin-like behavior. Another possible experiment is to see how our optogenetic constructs 
behave over time intervals longer than the ones utilized in this work to monitor whether 
optogenetic cofilin-actin rods retain their reversibility long-term. What is also essential that we 
expand the studies to a neural cell and cultured neurons so the big question can be answered, 
what is the role of cofilin-actin rods in AD? To do this, we must have the biologically relevant 
cell line; possible choices are Neuro-2a or SH-SY5Y. Neuro-2a cells originate from a mouse and 
can exhibit responses to toxins which includes our oxidant. The cell line has been used to study 
neurite outgrowth and Alzheimer’s disease More studies into how cofilin-actin rods affect other 
AD precursors such as Aβ peptides, tau peptide, and tau phosphorylation would be of interest. 
We should also explore how our constructs affect neuronal viability and function. Overall, we 
have shown that we have created a protocol and an optogenetic construct where we can recreate 
the phenomena of cofilin-actin rods. We have created optogenetics constructs that are reversible 
when exposed to blue light and a way to screen for compounds to prevent rod formation. Future 
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